Prenatal cannabinoid exposure: why expecting individuals should take a pregnancy pause from using cannabinoid products.  Lin A, Dent GL, Davies S, Dominguez ZM, Cioffredi LA, McLemore GL, Maxwell JR.  Front Pediatr. 2023 Oct 11;11:127822...

Systematic Review of Clinical Practice Guidelines for Neonatal Abstinence Syndrome.  Wei Z, Gilbert Y, Thananjeyan A, Cope J, Morton RL, Li A, Pham CT, Ward M, Oei JL. A  Children (Basel). 2023 Oct 13;10(10):1685. doi: 10.3390/children10...

Visual function in Norwegian children aged 5-13 years with prenatal exposure to opioid maintenance therapy: A case-control study.  Aslaksen AK, Vikesdal GH, Voie MT, Rowlands M, Skranes J, Haugen OH.  Acta Ophthalmol. 2023 Sep 13. doi: 1...

A mini review of what matters in the management of NAS, is ESC the best care?  Gomez Pomar E.  Front Pediatr. 2023 Jul 14;11:1239107. doi: 10.3389/fped.2023.1239107. PMID: 37520058; PMCID: PMC10376704. https://www.ncbi.nlm.nih.gov/pmc/ar...

Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS).  Czynski A, Laptook A, Das A, Smith B, Simon A, Greenberg R, Annett R, Lee J, Snowden J, Pedroza C, Lester B,...

It's a proactive intervention instead of a reactive one": measuring facilitators and barriers regarding readiness to implement a treatment program for infants with neonatal opioid withdrawal syndrome.  Holcomb L, Koob C, Mayo R, Charron E, Di...